PRESS RELEASE published on 06/24/2025 at 15:05, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Spectris plc The Vanguard Group, Inc. discloses 5.48% stake in Spectris plc. Recent purchase of 5p ordinary shares. Disclosure under Rule 8.3 of the Takeover Code The Vanguard Group Stake Disclosure Purchase Of Shares Rule 8.3 Disclosure Spectris Plc
BRIEF published on 06/23/2025 at 16:39, 1 year 3 months ago The Vanguard Group, Inc. Discloses Position in Qualcomm Incorporated Takeover Code Vanguard Group Form 8.3 Disclosure Investment Positions Qualcomm Securities
BRIEF published on 06/23/2025 at 16:39, 1 year 3 months ago The Vanguard Group, Inc. révèle sa participation dans Qualcomm Incorporated Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Divulgation Positions D'investissement Qualcomm Securities
BRIEF published on 06/23/2025 at 16:39, 1 year 3 months ago The Vanguard Group Discloses Position in American Axle Financial Position Takeover Code Securities Disclosure Vanguard Group American Axle
BRIEF published on 06/23/2025 at 16:39, 1 year 3 months ago Le groupe Vanguard révèle sa position dans American Axle Groupe Vanguard Code De Prise De Contrôle Situation Financière Divulgation Des Valeurs Mobilières Essieu Américain
BRIEF published on 06/23/2025 at 16:38, 1 year 3 months ago The Vanguard Group Discloses Position in Dalata Hotel Group Form 8.3 Securities Disclosure Vanguard Group Dalata Hotel Irish Takeover
BRIEF published on 06/23/2025 at 16:38, 1 year 3 months ago Le groupe Vanguard révèle sa position dans le groupe hôtelier Dalata Groupe Vanguard Formulaire 8.3 Divulgation Des Valeurs Mobilières Hôtel Dalata Prise De Contrôle Irlandaise
BRIEF published on 06/23/2025 at 16:37, 1 year 3 months ago The Vanguard Group's Position on Mural Oncology plc Shares Ordinary Shares Disclosure Vanguard Group Irish Takeover Mural Oncology
BRIEF published on 06/23/2025 at 16:37, 1 year 3 months ago Position du groupe Vanguard sur les actions de Mural Oncology plc Groupe Vanguard Actions Ordinaires Divulgation Prise De Contrôle Irlandaise Oncologie Murale
BRIEF published on 06/23/2025 at 16:36, 1 year 3 months ago The Vanguard Group Discloses Interest in Greencore Group plc The Vanguard Group Stake Disclosure Share Dealings UK Takeover Code Greencore Group Plc
Published on 10/22/2026 at 23:30, 1 hour 36 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 2 hours 36 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 9 hours 6 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 10 hours 36 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/22/2026 at 14:00, 11 hours 6 minutes ago Jericho Energy Ventures Amends Investor Relations Agreement with Orange Group Advisors
Published on 10/22/2026 at 22:10, 2 hours 56 minutes ago Quantinuum to Report Third Quarter Financial Results on November 5, 2026
Published on 10/22/2026 at 20:00, 5 hours 6 minutes ago Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 19:45, 5 hours 21 minutes ago EUROPLASMA: Les Forges de Tarbes sollicitent l’ouverture d’une procédure de redressement judiciaire
Published on 10/22/2026 at 18:45, 6 hours 21 minutes ago Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany
Published on 10/22/2026 at 18:30, 6 hours 36 minutes ago lePERMISLIBRE annonce l’organisation d’une visioconférence destinée aux actionnaires et investisseurs
Published on 10/22/2026 at 18:00, 7 hours 6 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 7 hours 6 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 7 hours 6 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 7 hours 6 minutes ago bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Published on 10/22/2026 at 18:00, 7 hours 6 minutes ago 1er semestre 2026 : résultats opérationnels en nette amélioration
